Evotec SE (EVO) Other Operating Expenses (2009 - 2025)
Evotec SE (EVO) posted Other Operating Expenses of -$248.6 million for Q4 2025, down 478388.4% sequentially from -$51954.0 in Q3 2025, and down 246.79% YoY from $169.4 million in Q4 2024.
Evotec SE (EVO) Other Operating Expenses (2009 - 2025) Analysis & Trends
Evotec SE has reported Other Operating Expenses for 8 years, with the latest figure at -$248.6 million in Q4 2025.
- Quarterly Other Operating Expenses fell 246.79% year-over-year to -$248.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$248.6 million (down 246.63% YoY) and the FY2025 annual result came in at -$248.7 million, down 246.82% from the prior year.
- Other Operating Expenses eased to -$248.6 million in Q4 2025 per EVO's latest filing, from -$51954.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $77539.5 in Q4 2021 and troughed at -$256.5 million in Q4 2023.
- A 5-year average of -$38.4 million and a median of -$28830.2 in 2021 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses surged 173.17% in 2022, then tumbled 443169.24% in 2023.
- Over 5 years, Other Operating Expenses stood at $77539.5 in 2021, then slipped by 25.35% to $57882.7 in 2022, then sank by 443169.24% to -$256.5 million in 2023, then jumped by 72.05% to -$71.7 million in 2024, then plunged by 246.79% to -$248.6 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$248.6 million, -$51954.0, and -$71.7 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -248.59 Mn |
| Sep 30, 2025 | -51,953.98 |
| Dec 31, 2024 | -71.68 Mn |
| Sep 30, 2024 | -49,173.88 |
| Dec 31, 2023 | -256.46 Mn |
| Sep 30, 2023 | 54,441.50 |
| Jun 30, 2023 | -26,815.85 |
| Dec 31, 2022 | 57,882.71 |
| Sep 30, 2022 | 42,296.10 |
| Jun 30, 2022 | 21,223.76 |
| Mar 31, 2022 | -35,725.13 |
| Dec 31, 2021 | 77,539.50 |
| Sep 30, 2021 | 29,988.10 |
| Jun 30, 2021 | -29,006.08 |
| Mar 31, 2021 | -28,830.25 |
| Dec 31, 2020 | 80,130.22 |
| Sep 30, 2020 | 23,075.37 |
| Sep 30, 2010 | 3,250.13 |
| Jun 30, 2010 | 4,510.38 |
| Mar 31, 2010 | -1,241.44 |